Conference Call Scheduled for today, November 13, 2025, at 5:00pm ETGARDNER, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its first quarter fiscal year 2026 for the period ended September 30, 2025. Q1 2026 Financial Highlights (3 Months Ended September 30, 2025): Revenue was $6.7 million, a q ...

Core Viewpoint - Precision Optics Corporation will participate in the Lytham Partners Fall 2025 Investor Conference, hosting a webcast presentation and one-on-one meetings with investors on September 30, 2025 [1][2][3]. Company Overview - Precision Optics Corporation, founded in 1982, is a vertically integrated optics company focused on advanced optical instruments for the medical and defense/aerospace industries [4]. - The company leverages proprietary micro-optics, 3D imaging, and digital imaging technologies to provide services from product concept to mass manufacture [4]. - Precision Optics supports next-generation medical device companies by providing enhanced imaging systems for minimally invasive surgery and 3D endoscopy systems [4]. - The company has a long history of supplying optical products, including complex endocouplers and specialized endoscopes, to top-tier medical device companies [4]. - In the defense/aerospace sector, Precision Optics applies its technical proficiency in micro-optics to meet high-quality standards while optimizing size, weight, and power [4].

Core Insights - Precision Optics Corporation reported a record quarterly revenue of $6.2 million for Q4 2025, representing a 31% increase year-over-year, driven by strong demand from aerospace and surgical robotics sectors [6][7] - The company anticipates fiscal year 2026 revenue to exceed $25 million, indicating over 30% growth compared to fiscal year 2025 [6][8] - The appointment of Joseph Traut as the new Chief Operating Officer is expected to enhance operational efficiency and production capacity [9][10] Financial Highlights for Q4 2025 - Quarterly revenue reached $6.2 million, up from $4.7 million in Q4 2024, marking a growth of approximately 31% [6][7] - Production revenue was $5.1 million, a 54% increase from $2.8 million in the same quarter last year [7] - Gross margins decreased to 13.0% from 21.7% in the same quarter of the previous fiscal year [7] Financial Highlights for FY 2025 - Total revenue for FY 2025 was $19.1 million, consistent with the previous fiscal year [7][24] - Production revenue increased by 34% to $14.2 million compared to $10.6 million in FY 2024 [7] - The net loss for FY 2025 was $(5.8) million, compared to $(3.0) million in FY 2024 [7][24] FY 2026 Financial Guidance - The company projects FY 2026 revenue to exceed $25 million, representing a growth of approximately 31% over FY 2025 [6][8] - Expected gross margin for FY 2026 is approximately 30%, an improvement from 18% in FY 2025 [7][8] - Projected Adjusted EBITDA for FY 2026 is approximately $0.5 million, compared to $(3.7) million in FY 2025 [7][8] Operational Challenges and Improvements - Margins were impacted by production yields, staffing, and efficiency challenges, along with unexpected tariff costs [8] - The company has renegotiated pricing agreements to address yield shortfalls and anticipates improvements in gross margins throughout FY 2026 [8] - New product development initiatives are expected to enhance the utilization of engineering resources [8] Leadership Changes - Joseph Traut has been appointed as the new Chief Operating Officer, effective October 1, 2025, bringing extensive experience in operations management within the medical device sector [9][10] - The company expects Traut's expertise to contribute significantly to scaling operations and improving manufacturing efficiency [10]

Core Insights - Precision Optics Corporation will participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025 [1][2] - The company specializes in advanced optical instruments for the medical and defense/aerospace industries, leveraging proprietary technologies [3] Company Overview - Founded in 1982, Precision Optics is a vertically integrated optics company focused on micro-optics, 3D imaging, and digital imaging technologies [3] - The company provides services from product concept to mass manufacture, utilizing in-house design, prototype, regulatory, and fabrication capabilities [3] - In healthcare, Precision Optics supports the demand for enhanced imaging systems for minimally invasive surgery and 3D endoscopy systems [3] - The company has a long history of supplying optical products, including complex endocouplers and specialized endoscopes, to top-tier medical device companies [3] - In defense/aerospace, Precision Optics applies its micro-optics expertise to meet high-quality standards and optimize size, weight, and power [3]

Core Viewpoint - Precision Optics Corporation is set to announce its third quarter fiscal year 2025 financial results on May 15, 2025, followed by a conference call to discuss these results [1][2]. Company Overview - Precision Optics Corporation, founded in 1982, specializes in advanced optical instruments for the medical and defense/aerospace industries, focusing on micro-optics, 3D imaging, and digital imaging technologies [5]. - The company provides comprehensive services from product concept to mass manufacturing, leveraging in-house design, regulatory, and fabrication capabilities [5]. - In healthcare, Precision Optics supports the development of enhanced imaging systems for minimally invasive surgeries and 3D endoscopy systems, catering to the needs of surgical robotic systems [5]. - The company also applies its micro-optics expertise to defense/aerospace applications, emphasizing high quality and optimization of size, weight, and power [5]. Conference Call Details - The conference call is scheduled for May 15, 2025, at 5:00 p.m. ET, with access available via phone or live webcast [3]. - Call-in numbers include (844) 735-3662 or (412) 317-5705, and the webcast can be accessed at https://app.webinar.net/XMqWYwq1mQa [3]. - A replay of the call will be available for seven days, with specific access numbers and a replay code provided [4].